FUROSEMIDE DISPOSITION IN CIRRHOTIC-PATIENTS

被引：0
作者：
SAWHNEY, VK
GREGORY, PB
SWEZEY, SE
BLASCHKE, TF
机构：
[1] STANFORD UNIV,MED CTR,SCH MED,DIV CLIN PHARMACOL,STANFORD,CA 94305
[2] STANFORD UNIV,MED CTR,SCH MED,DEPT MED,DIV GASTROENTEROL,STANFORD,CA 94305
来源：
GASTROENTEROLOGY | 1981年 / 81卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1012 / 1016
页数：5
相关论文
共 18 条
[1]  
ANDREASEN F, 1974, ACTA PHARMACOL TOX, V35, P49
[2]   NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].
BENET, LZ ;
GALEAZZI, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074
[3]   PHARMACOKINETICS-PHARMACODYNAMICS OF FUROSEMIDE IN MAN - REVIEW [J].
BENET, LZ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1979, 7 (01) :1-27
[4]  
BOXENBAUM HG, 1977, J PHARMACOKIN BIOPHA, V5, P161
[5]   DETERMINANTS OF RESPONSE TO FRUSEMIDE IN NORMAL SUBJECTS [J].
BRANCH, RA ;
ROBERTS, CJC ;
HOMEIDA, M ;
LEVINE, D .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (02) :121-127
[6]   PHARMACODYNAMIC ANALYSIS OF THE FUROSEMIDE-PROBENECID INTERACTION IN MAN [J].
CHENNAVASIN, P ;
SEIWELL, R ;
BRATER, DC ;
LIANG, WMM .
KIDNEY INTERNATIONAL, 1979, 16 (02) :187-195
[7]  
FOGEL MR, J CLIN GASTROENTEROL
[8]   OPTIMAL DIURETIC REGIMEN FOR CIRRHOTIC ASCITES - CONTROLLED TRIAL EVALUATING SAFETY AND EFFICACY OF SPIRONOLACTONE AND FUROSEMIDE [J].
FULLER, RK ;
KHAMBATTA, PB ;
GOBEZIE, GC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1977, 237 (10) :972-975
[9]  
GIBALDI M, 1975, PHARMACOKINETICS, P69
[10]  
HONARI J, 1977, CLIN PHARMACOL THER, V22, P395
12